VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETESPR Newswire • 1 day ago
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE...
Share to Feed
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced important advancements across its suzetrigine pain program, which has the potential to be the first new class of medicine for acute...
:max_bytes(150000):strip_icc()/GettyImages-2102401647-7d1f2f62710e4fdf8ae272343c1b24bf.jpg)
Justin Sullivan / Staff / Getty Images
Key TakeawaysU.S. equities were mixed at midday Thursday, April 11, 2024 as the latest report on inflation showed wholesale prices rose less than expected...
:max_bytes(150000):strip_icc()/GettyImages-2010459008-079015b576724d41a3092e1cfb3678d6.jpg)
News of the day for April 11, 2024
Michael M. Santiago / Getty Images
U.S. stock futures are edging lower in premarket trading after tumbling Wednesday on the back of a hotter-than-forecast...
:max_bytes(150000):strip_icc()/VRTXChart-16089af1405e4288a0e607c8ad87c01a.GIF)
Deal Values Each Alpine Share at a 38% Premium to Wednesday's Closing Price
Source: TradingView.com
Key TakeawaysVertex shares slipped in extended trading Wednesday after the company...
Biotech company Vertex Pharmaceuticals said it is acquiring Alpine Immune Sciences in a cash deal valued at $4.9 billion, the company said in a statement on Wednesday. Read more...
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion...
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Alpine Immune Sciences, Inc. (Nasdaq: ALPN), a biotechnology company focused on discovering and developing innovative, protein-based...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Alpine Immune Sciences, Inc. (Nasdaq: ALPN), a biotechnology company focused on discovering and developing innovative, protein-based...